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Eph and Ephrin Signaling in Mammary Gland
Morphogenesis and Cancer
Anne-Catherine Andres1 and Andrew Ziemiecki1,2
The Eph family of receptor tyrosine kinases and their membrane-bound ligands, the ephrins,
play a central role in pattern formation during embryonic development and there is growing
evidence that they are also instrumental in the control of tissue dynamics in the adult. The
mammary gland is a paradigm for morphogenic processes occurring in the adult, since the
gland develops predominantly postnatally and is subjected to continuous cyclic remodeling
according to functional demands. Thus, pattern formation and the establishment of a functional
organ structure are permanent themes in the mammary gland life cycle. In this paper we
summarize the experimental evidence and discuss possible mechanisms by which Ephs and
ephrins are modulating mammary epithelial cell adhesion, communication, and migration.
Furthermore, we speculate on the different aspects of their influence on normal mammary
gland development, function, and carcinogenesis.
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The proper development and functioning of the
mammary gland is strictly dependent on a complex in-
terplay of endo- and paracrine stimulation, cell–cell
communication, and cell–matrix interactions. In con-
trast to most organs, these morphogenic processes are
not limited to the embryonic period but occur mainly
postnatally. Thus, the mammary gland represents a
unique model to study developmental mechanisms
normally limited to the embryonic period. Studies
in many laboratories during the past 10 years have
revealed that the Eph receptor tyrosine kinase and
ephrin ligand families, by influencing cell adhesion
and/or migration, are effectors of many developmen-
tal processes, including segmentation, pattern forma-
tion, cell boundary formation, and cell guidance dur-
ing embryogenesis. In this paper we focus on the
involvement of these receptor–ligand families in the
postnatal morphogenesis of the mammary gland.
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THE Eph AND EPHRIN FAMILIES
The Eph receptor family, with 14 character-
ized members in mammals to date, represents the
largest family of RPTKs. The extracellular moiety
of these molecules consists of an immunoglobulin-
like globular domain involved in ligand interaction,
a cysteine-rich region and two fibronectin type III
repeats. A highly conserved motif, YIDPFTYEDP,
found in the internal juxtamembrane region of all
Eph family members participates by specific protein
interactions in downstream signaling complex for-
mation and in the regulation of the catalytic and
biological activity of the receptors. The kinase do-
main is located intracellularly together with a con-
served SAM thought to represent a protein-binding
module involved in developmental regulation. It is
Abbreviations used: FAK, focal adhesion kinase; GPI, glycosyl-
phosphatidylinositol; LTR, long terminal repeat; MMTV, mouse
mammary tumor virus; PDZ, postsynaptic density protein, disc
large, zona occludens; RPTK, receptor tyrosine kinase; SAM, ster-
ile alpha motif; SH2, Src homology domain-2; SH3, src homology
domain-3.
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speculated that the SAM motif participates in the for-
mation of heterodimers, thereby regulating receptor
oligomerization and activation. The C-termini of Eph
RPTKs have consensus PDZ binding motifs, which
can bind PDZ domain-containing proteins, many of
which are implicated in the formation of submembra-
nous scaffolds for the assembly of macromolecular
signaling complexes (Fig. 1(A)) (1,2).
The protein ligands of the Eph family, the
ephrins, are also membrane-associated, either by a
glycosy-phosphatidylinositol (GPI) anchor (ephrin-
A family) or as transmembrane proteins (ephrin-
B family). Extracellularly, the molecules consist of
the receptor binding domain containing a high affin-
ity receptor binding loop and a lower affinity inter-
face, probably mediating the formation of tetrameric
structures (Fig. 1(B)), (3). The intracellular moiety
of ephrin-B family members contains five tyrosine
residues conserved in location and amino acid con-
text. In addition, a PDZ binding motif is located at
the C-terminus of ephrin-B family members and has
been shown to interact with PDZ domain-containing
proteins (Fig. 1(A)) (1,2).
Although receptor–ligand interaction prefer-
ences have been observed, both receptors and ligands
are promiscuous and can interact with several part-
ners, albeit with different affinities. In general, EphA
receptors interact with ephrin-A ligands, whereas
EphB receptors preferentially bind to ephrin-B lig-
ands. Given the membrane-bound localization of both
receptors and ligands, it is not surprising that ligands
have been reported to be most effective in receptor
activation when cell surface-bound and clustered. The
cytoplasmatic domain of the ephrin ligands undergoes
phosphorylation on conserved tyrosine residue(s) fol-
lowing receptor interaction in vitro and in vivo (1,2).
Thus, SH2-driven signaling cascades can ensue not
only from the receptors but also from the ligands,
provoking bidirectional signaling and mutual cell–cell
communication (Fig. 1(B)). Possible mechanism(s)
for modulating both receptor and ligand activities ex-
ist. Both molecule types have been shown to associate
with phosphatases (1,2), and, recently, an extracellu-
lar metalloprotease, Adam 10, has been found to asso-
ciate with ephrin-A ligands. This protease is activated
following receptor engagement and cleaves the ex-
tracellular moiety of the ligand molecule, terminating
ligand signaling and the physical association between
cells (4).
Intracellularly, a wide range of molecules has
been implicated in the propagation of Eph and
ephrin-derived signals, including SH2 and SH3
Fig. 1. (A) Schematic representation of the structure of the Eph re-
ceptors and ephrin ligands. The A-type ephrins (membrane bound
via GPI-tail) and B-type ephrins (transmembrane molecules with
conserved intracellular tyrosine residues) are structurally distinct.
A- and B-type receptors are structurally similar and are grouped
according to their preferences in ligand interaction. (B) Schematic
representation of the interaction between EphB receptors and
ephrin-B ligands. Receptor–ligand interaction leads to the dimer-
ization and concomitant tyrosine phosphorylation of both receptor
and ligand. Signaling cascades can ensue from both receptor and
ligand, provoking a plurality of responses affecting cell shape, ad-
hesion, and migration.
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Table I. List of Molecules Known to Either Interact or Communicate With Eph Receptors and




Rho and Ras family of small GTPases Wnt signaling pathway
Exchange factors ephexin, intersectin, kalirin Ryk
Adaptor proteins Crk, Grb7, Grb2, Grb10, Shc, Nck, Cbl NMDA receptors
Docking protein Cas T-cell receptor






GTPase-activating protein PDZ-RGS3 Wnt signaling pathway
Kinases FAK, src, fyn FGF-receptor
Adaptor protein Grb4 PDGF-receptor
Phosphatase PTP-BL Tie-2
Protease Adam-10
domain-containing kinases and adapter proteins,
PDZ domain-binding proteins and the Rho, Rac,
and Ras family of GTPases (1,2) (Table I). Al-
though the plurality of effects observed upon Eph
and ephrin stimulation is large, a common theme ap-
pears to be the modulation of adhesive and/or migra-
tory properties of cells by targeting the cytoskeleton
(Fig. 1(B)) (5).
The observation that Eph receptors and their
ligands exhibit reciprocal expression patterns during
embryonic development has led to the suggestion that
these molecules play a role in the development and
patterning of a variety of tissues during embryoge-
nesis. Indeed, Eph and ephrin family members have
been shown to be involved in gastrulation, cell mi-
gration from the neural crest, segmentation of the
early embryo, and formation of the somites. In the
developing nervous system, they play a pivotal role in
axon guidance and fasciculation. Furthermore, these
molecules are involved in cell sorting and restriction
of intermingling and communication resulting in tis-
sue boundaries (6,7). EphB2, -B3 and -B4 and ephrin-
B1 and -B2 also participate in the adhesive response of
endothelial cells during embryogenesis. Ephrin-B2 is
exclusively expressed in embryonic arteries, whereas
EphB4 marks the embryonic veins. Disruption of ei-
ther gene causes embryonic lethality by E10.0 and
is accompanied by defects in early vascular develop-
ment and myocardial trabeculation in the heart (8).
In contrast to embryonic development, little is
known about the function(s) of the Eph and ephrin
families in postnatal and adult life. Some members are
expressed in adult organs, such as mammary gland,
kidney, and lung (9), and ephrin-B2 expression has
been demonstrated in adult arteries of varied diam-
eter, in subsets of microvessels at sites of adult neo-
vascularization and within experimental tumor vas-
culature. Furthermore, ephrin-B2 expression has also
been observed in vascular smooth muscles of arteries
but not veins (10,11). These observations suggest that
members of the Eph and ephrin families are also in-
strumental in inductive cell movement, structure for-
mation, and homeostasis in the adult.
In conclusion, Ephs and ephrins are mul-
tifunctional molecules governing the control of
proliferation and death, cellular shape, cell adhesion,
and repulsion. They exhibit a complex mechanism of
activation and action depending on the environment.
Signaling can occur either unidirectionally or bidirec-
tionally and ligand–receptor interactions are highly
promiscuous. Furthermore, receptor activation can
occur in the absence of ligand and receptor and/or
ligand activation can also be achieved by cross-talk
with other cell signaling pathways (1,2,7) (Table I).
Eph AND EPHRIN EXPRESSION
IN THE MAMMARY GLAND
Although a systematic survey of Eph and ephrin
expression in the mammary gland is lacking, several
studies have shown that at least some family mem-
bers are differentially expressed in this organ. The
EphB4 receptor, originally isolated from mouse mam-
mary epithelial cells (9), is expressed in myoepithelial,
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luminal, and ductal epithelial cells predominantly dur-
ing puberty and the follicular phase of the estrus cycle
in mice and humans (9,12,13). Estrogen is one of the
mediators conferring this tight control of expression.
Ovariectomized mice fail to express EphB4, and ad-
ministration of estrogen can restore expression (12).
Estrogen control is likely to occur at both the tran-
scriptional and posttranscriptional levels. Although
estrogen-responsive elements are found in the pro-
moter region of both the EphB4 and ephrin-B2 genes
(unpublished observation), the estrogen effects are
most evident at the protein level, a phenomenon also
observed for other Eph genes (12,14). Interestingly,
the opposite effect of estrogen on EphB4 expression
has been documented in the glandular epithelium of
the endometrium, suggesting that EphB4 is either dif-
ferentially controlled by the different estrogen recep-
tors or that cell-type specific conversion of the estro-
gen signal may lead to the differential response (15).
In addition to EphB4, developmentally controlled ex-
pression of EphA2 in the mammary epithelium has
also been reported (9,16). Furthermore, in vitro stud-
ies have shown that EphA2 expression is negatively
regulated by estrogen and c-myc (17). The cognate
EphB4 ligand, ephrin-B2, shows a similar cell-type
specific expression in the mammary gland, however,
with less strict hormonal control (12).
In addition to estrogen, transcription factors of
the Tcf family may also contribute to the specific ex-
pression of Eph and ephrins in the mammary gland.
Members of this family of transcription factors have
been implicated in the establishment of epithelial
cell fate predominantly in intestine, skin, and the
mammary gland (18). In the intestine, Tcf has been
shown to simultaneously stimulate the expression of
EphB receptors and repress transcription of ephrin-B
ligands (19).
Eph AND EPHRIN INVOLVEMENT IN
MAMMARY GLAND MORPHOGENESIS
The morphogenesis of the mammary gland is ac-
complished by locally regulated cell proliferation and
pattern formation involving controlled bifurcations of
the growing ducts and the development of functional,
secretory lobulo-alveolar units. At birth, a modestly
ramifying mammary ductal system extends under the
skin in a small mass of adipose tissue. With the onset
of ovarian function, the epithelial ducts elongate by
massive directional growth of the end-buds, which in-
vade the fatty stroma and by twisting and branching
give rise to the adult ductal network capable of growth
and differentiation during each pregnancy. Eph and
ephrins are instrumental in cell guidance during em-
bryonic development. Depending on the microenvi-
ronment and the identity of interacting partners, Eph
and ephrin activation can exert cellular repulsion, ad-
hesion, or attraction (20). The molecular mechanisms
responsible for the cyclic pattern formation of the
mammary ductal tree are largely unknown. However,
emerging experimental evidence implicates members
of the Eph and ephrin families either directly or via




The dynamic structure of the mammary gland de-
pends on the ability to form and disassemble cell–cell
contacts. There is compelling evidence that Eph and
ephrin are controlled by or are controlling cell–cell
adhesion complexes. A major component of cell ad-
hesion complexes are the cadherins, which play an
important role in the establishment of the mammary
ductal tree. The bilayered structure of the mammary
epithelial duct is established in the end-bud, where
the cap cells comprise a monolayer of stem cells over-
lying a population of cells giving rise to the luminal
epithelial cells. Cap cells develop either into myoep-
ithelial cells or migrate into the luminal compartment
to constitute the stem cell population (21). It has been
shown that P-cadherin on cap cells and E-cadherin on
the luminal cells are instrumental in the organization
of these two compartments, and E-cadherin-mediated
cell contacts are a prerequisite for the formation of
a functional secretory epithelium (22). Interestingly,
Eph and ephrin expression can be modulated by E-
cadherin. It has been shown in embryonic stem cells
that disruption of E-cadherin expression leads to the
induction of the EphB2 and -B4 receptors and ephrin-
B1 and -B2 ligands. In contrast, loss of E-cadherin
expression resulted in the loss of the expression of
EphA receptors (23). Moreover, membrane local-
ization and phosphorylation of EphA2 is dependent
on E-cadherin-mediated cell adhesion in breast ep-
ithelial cells (24). In light of these observations, it
is tempting to speculate that EphA receptors are
predominantly involved in anchoring epithelial cells,
whereas EphB receptors and ephrin-B ligands are in-
strumental in guided cell migration. Applied to the
mammary gland, Eph and ephrins may participate in
the cadherin-mediated compartmentalization of the
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mammary epithelial cells, with type A signaling sup-
porting luminal cell adhesion and type B signaling
determining epithelial outgrowth and migration.
In addition to the cadherins, AF6 protein is a
component of adherens and tight junctions, and its
absence correlates with disruption of epithelial cell–
cell junctions and cell polarity during mouse devel-
opment (25). AF6 has been shown to interact di-
rectly with several members of the Eph family via
its PDZ domain; in the case of EphB3 this interac-
tion is dependent on receptor activation (26). In ad-
dition, AF6 is a target for the Ras family of proteins
(27). In this context, the interactions of Ephs with
the Ryk receptor are of particular interest. Ryk is
an orphan receptor with no intrinsic catalytic activ-
ity. It is expressed predominantly during embryonic
development, but also in the adult mammary epithe-
lium (28–30). Murine EphB2 and EphB3 interact with
Ryk, leading to its activation by phosphorylation and
provoking the association of these three proteins with
AF6, thereby stabilizing junctional complexes (31).
Interestingly, Ryk¡ mice have a cleft palate, a compa-
rable phenotype as observed in EphB2/EphB3 dou-
ble knockout mice, supporting the postulated coop-
eration between these two molecules in morphogenic
processes (32). These observations strongly implicate
Ephs and ephrins as potential modulators of cell–cell
contacts at different levels of cell junction signaling
Eph/Ephrin Cross-Talk With
Focal Adhesion Complexes
In addition to cell–cell communication, interac-
tions with the extracellular matrix are necessary for
the proper development of the mammary gland. Cor-
rect functioning of the integrins is essential for the
shaping of mammary epithelial cells and for their se-
cretory activity (33) (for more details see articles by
Glukhova and Streuli in this issue). Both Eph recep-
tors and ephrin ligands have been shown to interact
and cross-talk with the integrin signaling cascade at
different levels, implicating them in an additional as-
pect of mammary gland function. EphA receptors
have been reported to suppress integrin signaling,
whereas a promoting effect has been ascribed to EphB
receptors (34–37). This crosstalk can occur at different
molecular levels: via dissociation and redistribution
of focal adhesion complex components such as FAK
and paxillin (35), via phosphorylation and modulation
of the activities of the small GTPases R-ras and Rap1
(36) and via transient or constitutive interactions with
PI-3 kinase (38–40). Similarly, the ephrins are capa-
ble of modulating cell adhesion by increasing FAK
activity, redistributing paxilin and disassembly of fo-
cal adhesions (41). In conclusion, Eph and ephrins
seem to be involved in the fine tuning of basement
membrane anchoring and detachment, an aspect of
particular importance during the dynamic states of
mammary gland development. Indeed, expression of
Eph and ephrins is predominantly observed during
puberty and the estrous cycle and is downregulated
during the differentiated, rather static state at end-
pregnancy and lactation (9,12).
Eph/Ephrin Cross-Talk With Wnt Signaling
As already mentioned, Eph/ephrin expression
can be modulated by members of the Tcf transcrip-
tion factor family. The activity of Tcf is dependent on
the availability of cytoplasmic free fl-catenin which
in turn is controlled by the Wnt signaling pathway
(42). Members of the Wnt family are differentially
expressed during mammary gland development, and
Wnt-4 signaling has been shown to be essential in me-
diating progesterone function during mammary gland
morphogenesis (43,44) (for more details see paper by
A. Clarke in this issue). These observations implicate
direct cross-talk between the Eph/ephrin and Wnt sig-
naling pathways during mammary gland development
and functioning.
A potentially important implication of this cross-
talk in mammary gland biology may concern the con-
trol of stem cell fate. The capacity of the mammary
gland to undergo cyclic functional development upon
demand is thought to originate from multipotent stem
cells scattered along the ductal tree which are capa-
ble of self-renewal and differentiation into the var-
ious types of epithelial cells present in the lactat-
ing mammary gland (45). There is presently little
experimental information available how the distri-
bution, maintenance, regeneration, and differentia-
tion of the mammary stem cells are regulated at the
molecular level. The Wnt signaling cascade has been
implicated in the maintenance of stem cell popula-
tions in various organ systems; however, the mech-
anisms by which Wnt sustains stem cell populations
remain unclear (46). The recent observations made
in intestinal villi may serve as a possible model for
mammary regeneration. It has been shown that the
fl-catenin/Tcf- regulated expression of EphB2 and
EphB3 and ephrin-B1 and -B2 demarcate the pro-
liferative stem cell population from the differenti-
ating cells, respectively (19). The molecular mecha-
nisms regulating proliferation versus differentiation
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involve pathways modulating cell adhesiveness and
migration, notably the Rac/Rho/Ras GTPases and
the MAP kinase pathway, key intracellular targets of
Eph–ephrin signaling (1,2). As mentioned above, se-
lective expression of cadherins, in addition to Wnt, are
involved in the formation of the mammary stem cell
population. Bearing in mind that Eph and ephrins par-
ticipate in cross-talk with both families of molecules,
it is tempting to speculate that they are also involved
in the regulation of distribution, proliferative activ-
ity, and fate of the mammary epithelial stem cells.
The dissection of the molecular pathways, however,
is hampered by the fact that, in contrast to the well-
demarcated location of stem cells in the gut, the mam-
mary stem cells are randomly scattered in the epithe-
lial ducts, and well-defined molecular stem cell mark-
ers are lacking.
EXPERIMENTAL EVIDENCE FOR A ROLE
OF Eph AND EPHRIN IN MAMMARY
GLAND BIOLOGY
To date, direct experimental evidence for the
involvement of members of the Eph/ephrin families
in the development of the mammary gland is limited
to studies of transgenic mice expressing the EphB4
receptor gene under the control of the MMTV-LTR
promoter (47). These transgenic mice exhibit strong
Fig. 2. Semithin sections of lactating mammary glands of control and EphB4 transgenic mice. 1 „ sections were stained with toluene
blue. Note the regular appearance of the secretory epithelium in control mammary glands with numerous vesicles reflecting their
secretory activity. Dark spots in the lumen indicate secreted milk fat globules. In contrast, the epithelium of EphB4 transgenic
mammary glands exhibits a highly irregular structure with many bright and fragile looking cells lacking secretory activity. In addition,
clefts between the epithelial cells indicate disturbances in cell–cell interactions.
EphB4 expression in the mammary epithelium dur-
ing pregnancy and lactation, developmental stages
at which the expression of the endogenous gene
is downregulated. The phenotypic consequences
observed in the mammary glands of these mice
include delayed epithelial proliferation during preg-
nancy and suppression of epithelial cell death at the
onset of postlactational involution. Furthermore, the
mammary parenchyma is characterized by the de-
velopment of fewer side-branches during pregnancy
which, however, are composed of more but smaller
lobulo-alveolar units than those of control mice. At
lactation, the secretory alveolar cells exhibit a highly
irregular morphology, with many epithelial cells exfo-
liating into the lumen. Moreover, the regional absence
of milk fat globules indicates disturbance of their
secretory capacity (Fig. (2)) (47).These data directly
implicate the EphB4 receptor in the regulation of the
patterning of the mammary ductal tree, the epithelial
architecture and response to growth controlling
signals.
REMODELING OF THE VASCULATURE
DURING THE MAMMARY GLAND
LIFE CYCLE
The mammary gland life cycle is exemplified by
massive changes in cell number and composition,
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Fig. 3. Scanning electron microscopy photographs of corrosion casts of the mammary gland vasculature at lactation. (A) control;
(B) EphB4 transgenic.
architecture, and functionality. These drastic up-
heavals also involve the mammary endothelial
component, which undergoes angiogenic expansion
and regression according to physiological demand
(48). These events necessitate coordinated commu-
nication between the mammary endothelium, the
parenchyme, and the stromal components in order to
accommodate the changing demands. Indeed, the in-
teraction between mammary endothelial and epithe-
lial cells is not only crucial for vascular development
but is also a prerequisite for branching ductal-alveolar
morphogenesis (49).
Members of the Eph and ephrin families, notably
EphB4 and ephrin-B2, have been implicated not only
in the development of the embryonal vasculature but
also in neo-vascularization in the adult (8,10,11). In
particular, EphB4 and ephrin-B2 appear to mediate
critical communication between the arterial and ve-
nous endothelia (50). Moreover, nonendothelial ex-
pression of EphB receptors has been implicated in
endothelial cell guidance (8). In cell culture, stromal
expression of EphB4 results in the attenuation of en-
dothelial cells and inhibition of the formation of a
vascular network. In contrast, stromal expression of
ephrin-B2 results in the stimulation of endothelial cell
proliferation and sprouting (51).
Direct evidence for the involvement of the
EphB4 receptor in vascular development in the
mammary gland has been obtained using trans-
genic mice expressing the MMTV-LTR-EphB4 trans-
gene. Mercox corrosion cast visualization of the
mammary gland vasculature at lactation revealed
in control animals a well-developed, highly regular
vascular network, each alveolus being surrounded
by a honeycomb-like capillary plexus (Fig. 3(A)).
In contrast, the vasculature in lactating mammary
glands of the EphB4 transgenic animals exhib-
ited a distinctly irregular structure; many of the
honeycomb-like structures were poorly discernible,
partly collapsed, and aggregated. Furthermore, the
capillaries varied considerably in size, and bun-
dles of very thin, disorganized capillaries were
observed locally (Fig. 3(B) and unpublished obser-
vations). The conclusion that unscheduled expres-
sion of EphB4 may interfere with vascular archi-
tecture is further supported by observations made
in the kidney of these transgenic mice. In addition
to the expression in the mammary gland, EphB4
transgene expression was also observed in the ep-
ithelial cells constituting the proximal tubules and
Bowman’s capsule of the kidney. This unsched-
uled expression correlated with abnormal develop-
ment of glomerular vasculature and shunt forma-
tion reminiscent of aglomerular vascular shunts, a
human degenerative glomerulopathy of unknown
aetiology (52).
INVOLVEMENT OF Ephs AND EPHRINS IN
MAMMARY GLAND CARCINOGENESIS
Thus far, evidence for the carcinogenic potential
of Ephs and ephrins is scarce, and no mutations in
human breast cancer have been tightly linked to Eph
or ephrin genes (53). The expression of the EphB4
receptor protein has recently been analyzed in hu-
man breast cancers (13). In the normal breast EphB4
was expressed in ductal and luminal epithelial cells,
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predominantly during the follicular phase of the es-
trus cycle. Carcinogenesis was characterized by the
loss of EphB4 expression and correlated with tumor
progression. Interestingly, in advanced tumors single
tumor cells strongly expressing EphB4 were observed
in the border region between tumor nodules and the
surrounding mesenchyme.
More precise information about the involvement
of Eph or ephrin in carcinogenic processes has been
obtained from cell culture and transgenic mouse mod-
els. Overexpression of the EphA2 protein has been
observed in a variety of human breast cancer cell
lines, and transfection of normal human breast epithe-
lial cells with EphA2 was sufficient to induce trans-
formation. Interestingly, in both cases the EphA2
molecules remained unphosphorylated, and induc-
tion of phosphorylation by exogenous administration
of the relevant ephrin-A1 ligand could revert the
transformed phenotype (16,54). These data suggest
that the Ephs may exert their oncogenic potential
in the absence of receptor phosphorylation, in con-
trast to the oncogenic mechanisms proposed for most
receptor tyrosine kinases. Expression of EphA2 and
its ligand ephrin-A1 has been demonstrated in the
vasculature of human primary breast cancers and of
breast-tumor-cell-line-derived tumors in nude mice
(55). Thus, EphA2 may be directly involved in tumor-
induced angiogenesis, a conclusion supported by the
observation that soluble EphA2 receptors are capable
of blocking blood vessel recruitment by breast tumor
cells (56).
In the EphB4 transgenic mice, EphB4 overex-
pression per se never gave rise to mammary tumors;
however, crossing these animals with MMTV-c-erbB2
transgenic mice led to an approximately 50% reduc-
tion of tumor latency in the double transgenic ani-
mals compared to the single transgenic c-erbB2 mice.
Moreover, in contrast to the single transgenic c-erbB2
mice, the double transgenic animals rapidly devel-
oped metastases to the lungs (47). These data indi-
cate that unscheduled expression of EphB4 can con-
tribute to the establishment of an aggressive tumor
phenotype.
These limited experimental data support the con-
cept that Eph and ephrins are not directly involved
in the control of cell proliferation and induction of
carcinogenesis, but rather contribute to tumor pro-
gression and metastasis formation (57). The acquisi-
tion of an invasive and metastatic phenotype requires
loss of cell contacts to neighboring cells, transient
change or loss in integrin-mediated attachment to
the basement membrane, invasion into the surround-
ing stroma, penetration into the blood stream, and
finally extravasation into a permissive tissue, which
sustains their further growth. It is conceivable that
Eph and ephrin participate at all these levels. Loss of
E-cadherin expression, a common feature of almost
all carcinomas (58), may impede EphA function and
induce EphB expression, allowing migration through
the tissue. Moreover, Eph–ephrin signaling can lead
to dissociation of focal adhesion points, thereby facili-
tating the detachment from the basement membrane.
Furthermore, Eph and ephrins are instrumental in the
formation of a functional vascular network during tu-
mor angiogenesis (10,11). The microvascular density
in tumors in turn not only ensures sufficient nutrient
supply for growth but also increases the chance of in-
vasive tumor cells entering the blood stream. Finally,
the adhesive/repulsive function of Eph and ephrins
may facilitate the seeding of tumor cells in a permis-
sive environment.
An alternative possibility, by which Eph and
ephrin may contribute to tumor progression, may lie
in their postulated involvement in mammary stem cell
demarcation, maintenance and differentiation (see
above). The classical cancer stem cell hypothesis im-
plicates mutations in this cell population as a poten-
tial source of tumorigenic cancer cells. Recent studies
have shown that only a small subset of human breast
tumor cells is capable of efficiently forming tumors in
an immunocompromised mouse model. These cells
were characterized by shared cell surface markers
reminiscent of a stem cell population (59). Conceiv-
ably, modulated Eph and ephrin expression may favor
the release, migration, and seeding of initiated mutant
stem cells.
CONCLUSIONS
Members of the Eph and ephrin families, con-
tribute to pattern formation by governing cell adhe-
sion, repulsion, movement, and intermingling. These
processes are not only prevalent during embryonic de-
velopment but also persist in adult organs subjected to
continuous tissue dynamics, such as the vasculature,
the intestine, the reproductive organs, and the mam-
mary gland. Through their ability to interact not only
with each other but also with other signaling pathways
and molecules involved in cell–cell contacts or cell–
matrix interactions, Ephs and ephrins may participate
in different aspects of mammary gland morphogene-
sis summarized in Fig. 4.
Figure 4, 1&2: The Eph/ephrin families may be
involved in the maintenance, demarcation and control
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Fig. 4. Schematic representation of the possible functions of Eph receptors and ephrin ligands in mammary
gland morphogenesis superimposed on a whole mount preparation of a mammary gland of a 10-week-old
virgin mouse. Note the faintly stained blosod vessels in contrast to the densely stained epithelial tree.
of fate of the stem cell population harboring the in-
tegrators of positive and negative mammatrophic sig-
nals. Many of these signals act in a complex of in-
terepithelial and paracrine interactions (60) in which
the Ephs and ephrins may represent additional mod-
ulators. This aspect of Eph and ephrin action would
not only ensure tissue regeneration and homeostasis
but may also have an impact on the susceptibility of
the mammary gland to malignant transformation.
Figure 4, 3&4: The organotypic growth of the
mammary parenchyma during puberty involves duc-
tal elongation and morphogenesis as well as pattern
formation by bifurcation of the terminal end-buds.
Although an understanding of the local paracrine
growth control is beginning to emerge (61), the
mechanisms responsible for guiding the growing ducts
through the fat pads, defining the frequency of bifur-
cation events, and determining the spacing between
the ductal structures are largely unknown. Similarly,
the regulation of lobulo-alveolar patterning and num-
ber remains unclear. Extrapolated from their known
function in guidance of cellular movement during
embryogenesis, Ephs and ephrins are probably also
instrumental in pattern formation in the pubertal
mammary gland and in lobulo-alveolar development
during pregnancy. This suggestion is supported by the
observation that mammary epithelial over-expression
of EphB4 during puberty resulted in growth retarda-
tion, reduced bifurcation, and the absence of second-
and third-order branching. Moreover, the intensity
of budding and lobule formation was diminished by
EphB4 expression during pregnancy (47).
Figure 4, 5: Through their ability to modulate
cell–cell and cell–matrix interactions, the Ephs and
ephrins are also likely to be implicated in the devel-
opment and maintenance of the alveolar structure at
lactation (Fig. 2). The ability to modulate cell adhesion
and migration represents an important aspect in the
development and maintenance of a functional organ
structure in this dynamic organ. This same property,
however, may also contribute to tumor progression.
Figure 4, 6: The above suggested roles of Eph
receptors and ephrin ligands represent direct mod-
ulations of mammary gland morphogenesis. These
molecules, however, may also have an indirect in-
fluence on growth and functioning of the mammary
gland through their capacity to influence the forma-
tion of a vascular network. Like every organ, proper
functioning of the mammary gland is dependent on an
adequate blood supply ensuring sufficient oxygena-
tion and nourishment and delivery of endocrine fac-
tors. Any disturbance in the extent and architecture
of the vasculature will probably affect the functioning
of the other organ components.
In summary, Eph receptors and ephrin ligands
are likely to be involved, either alone or in cooper-
ation with other signaling pathways, throughout the
entire mammary gland life cycle and are probable
P1: JQX
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candidates to fill the gaps in our understanding of
the regulatory mechanisms for multiple aspects of
mammary development. Their multifaceted functions
and signaling complexity represent a major challenge
to elucidating their individual contributions to mam-
mary gland development and functioning. Neverthe-
less, the necessary effort will be worth it and we would
like to close this paper by a citation from Cooke and
Moens (62): “Eph only it were simple: : : .”
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